Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti‐schistosomal Activity

The parasitic disease schistosomiasis is the cause of more than 200 000 human deaths per year. Although the disease is treatable, there is one major shortcoming: praziquantel has been the only drug used to combat these parasites since 1977. The risk of the emergence of resistant schistosomes is know...

Descripción completa

Detalles Bibliográficos
Autores principales: Peter Ventura, Alejandra M., Haeberlein, Simone, Lange‐Grünweller, Kerstin, Grünweller, Arnold, Hartmann, Roland K., Grevelding, Christoph G., Schlitzer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687077/
https://www.ncbi.nlm.nih.gov/pubmed/31454168
http://dx.doi.org/10.1002/cmdc.201900423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687077/
https://www.ncbi.nlm.nih.gov/pubmed/31454168
http://dx.doi.org/10.1002/cmdc.201900423

Ejemplares similares